You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Docetaxel

Showing 1 - 25 of 2,918
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Serplulimab,Gastric Cancer, Adjuvant Therapy Trial in Shanghai (Serplulimab, Docetaxel, S1)

Recruiting
  • Serplulimab,Gastric Cancer, Adjuvant Therapy
  • Shanghai, China
    Zhang Zizhen
Mar 3, 2023

Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Trial (Standard ADT (androgen deprivation therapy), Standard Darolutamide,

Not yet recruiting
  • Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
  • Standard ADT (androgen deprivation therapy)
  • +2 more
  • (no location specified)
Jan 6, 2023

Hyperthermic Intraperitoneal Chemo Trial in Guangzhou (Docetaxel)

Recruiting
  • Hyperthermic Intraperitoneal Chemotherapy
  • Docetaxel
  • Guangzhou, Other (Non U.s.), China
    Sun Yat-sen Memorial Hospital
Jun 6, 2022

Metastatic Castration-resistant Prostate Cancer Trial (Darolutamide, Docetaxel or cabazitaxel)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • (no location specified)
Feb 28, 2023

Advanced Solid Tumors Trial in Cangzhou (Docetaxel for Injection (Albumin-bound), Taxotere)

Active, not recruiting
  • Advanced Solid Tumors
  • Docetaxel for Injection (Albumin-bound)
  • Taxotere
  • Cangzhou, China
    Cangzhou Central Hospital
Jan 27, 2022

Prostate Cancer, Castrate Resistant Prostate Cancer Trial (Enzalutamide 40 MG, Docetaxel injection)

Not yet recruiting
  • Prostate Cancer
  • Castrate Resistant Prostate Cancer
  • Enzalutamide 40 MG
  • Docetaxel injection
  • (no location specified)
Jan 27, 2023

Hormone Sensitive Metastatic Prostate Cancer, DNA Damage Repair Deficiency, Chemo Effect Trial in Nanjing (Docetaxel,

Recruiting
  • Hormone Sensitive Metastatic Prostate Cancer
  • +3 more
  • Docetaxel
  • +2 more
  • Nanjing, Jiangsu, China
    Department of Urology, Drum Tower Hospital, Medical School of Na
Jul 13, 2022

Breast Cancer Trial in Beijing (QL1701, Herceptin®, Docetaxel)

Active, not recruiting
  • Breast Cancer
  • Beijing, China
    Cancer Hospital,Chinese Academy of Medical Sciences
Nov 18, 2022

Locally Advanced or Metastatic NSCLC Trial (Utidelone Injection, Docetaxel Injection)

Not yet recruiting
  • Locally Advanced or Metastatic Non-Small Cell Lung Cancer
  • Utidelone Injection
  • Docetaxel Injection
  • (no location specified)
Dec 30, 2022

NSCLC Trial (Pembrolizumab, Docetaxel)

Active, not recruiting
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Pembrolizumab
  • Docetaxel
  • (no location specified)
Aug 18, 2022

Pancreatic Cancer Trial in Shanghai (Docetaxel for injection (Albumin-bound))

Not yet recruiting
  • Pancreatic Cancer
  • Docetaxel for injection (Albumin-bound)
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Nov 13, 2022

Metastatic Castration-resistant Prostate Cancer Trial in La Jolla (Cirmtuzumab)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • La Jolla, California
    University of California San Diego
May 22, 2022

Docetaxel, Solid Tumours, Bioequivalence Trial in Andra, Gujrat, Mahara (BH009 (Docetaxel injection), Docetaxel injection)

Completed
  • Docetaxel
  • +2 more
  • BH009 (Docetaxel injection)
  • Docetaxel injection
  • Andra, India
  • +2 more
Dec 20, 2021

Breast Cancer Trial in Guandong (pegylated liposomal doxorubicin (PLD), cyclophosphamide (C), trastuzumab (H))

Recruiting
  • Breast Cancer
  • pegylated liposomal doxorubicin (PLD)
  • +5 more
  • Guandong, Guangdong, China
    Sunyat-sen Memorial Hospital
Feb 17, 2022

Breast Cancer Trial in Shanghai (KN026)

Recruiting
  • Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Cancer Hospital
Jun 16, 2022

Breast Tumors, Locally Advanced or Metastatic Breast Cancer Trial in Guangzhou (utidelone, docetaxel)

Not yet recruiting
  • Breast Neoplasms
  • Locally Advanced or Metastatic Breast Cancer
  • Guangzhou, Gangdong, China
    Shusen Wang
Jun 21, 2022

Breast Cancer, Chemo Effect Trial (Nab paclitaxel, Docetaxel)

Not yet recruiting
  • Breast Cancer
  • Chemotherapy Effect
  • Nab paclitaxel
  • Docetaxel
  • (no location specified)
Feb 11, 2022

Castration Resistant Prostatic Cancer Trial in Australia (Docetaxel intermittent, Docetaxel standard of care)

Recruiting
  • Castration Resistant Prostatic Cancer
  • Docetaxel intermittent
  • Docetaxel standard of care
  • Albury, New South Wales, Australia
  • +4 more
Feb 14, 2022

Sarcoma Trial in Santa Monica (Gemcitabine, Doxorubicin, Docetaxel)

Recruiting
  • Sarcoma
  • Santa Monica, California
    Sant P Chawla
May 4, 2022

Cohort Studies Trial in Jinan (apantamide+docetaxel+ADT, apantamide+ADT treatment)

Recruiting
  • Cohort Studies
  • Jinan, Shandong, China
    Qilu hospital
Feb 3, 2023

Gastric Adenocarcinoma, Adenocarcinoma of Gastroesophageal Junction Trial in Guangzhou (Docetaxel for injection (Albumin-bound),

Recruiting
  • Gastric Adenocarcinoma
  • Adenocarcinoma of Gastroesophageal Junction
  • Docetaxel for injection (Albumin-bound)
  • Taxotere
  • Guangzhou, China
    Ethics Committee of Sun-Yat-Sen University Cancer Center
Jan 27, 2023

Solid Tumor, Adult Trial in Amsterdam (ModraDoc006/r)

Withdrawn
  • Solid Tumor, Adult
  • Amsterdam, Netherlands
    Netherlands Cancer Institute - Antoni van Leeuwenhoek
Feb 7, 2022

NSCLC Trial in Guangzhou (Savolitinib, Docetaxel)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Guangzhou, Guangdong, China
    Department of Thoracic Surgery and Oncology, The First Affiliate
Mar 17, 2023

Breast Cancer Trial in Hangzhou (Docetaxel, Carboplatin, Trastuzumab)

Recruiting
  • Breast Cancer
  • Docetaxel
  • +6 more
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Jun 28, 2022

Effect of Drug Trial in Sapporo (Docetaxel, Pembrolizumab)

Not yet recruiting
  • Effect of Drug
  • Sapporo, Hokkaido, Japan
    Hokkaido University Hospital
Feb 12, 2022